retatrutide liver Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming Retatrutide Liver Fat Reduction: Evidence,

18 612 months: Sustained hormone improvements

I think menopause should be optional

Krom hjlper insulinet att transportera glukos in i cellerna dr den kan anvndas som energi

Food and Drug Administration (FDA) approved semaglutide for obesity management, marking a new milestone in the application of GLP-1RAs for weight loss (Jordan et al., 2024)

The findings reveal a fundamental change in how people eat, spend, and take care of themselves

A randomised trial found that patients who adhered to a low-calorie diet while on liraglutide lost significantly more weight than those who did not modify their diet, averaging an additional 3 kg over six months